Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial.
Taku AsanoToru TanigakiMasahiro HoshinoMotoki YasunagaHideaki NonakaHiroki EmoriYuki KatagiriYosuke MiyazakiYohei SotomiNorihiro KogameShoichi KuramitsuAkira SaitoKotaro MiyataYoshimitsu TakaokaTakayoshi KanieManabu YamasakiKunihiko YoshinoNaoki WakabayashiKouki OuchiHiroyuki KodamaYumi ShiinaRihito TamakiYosuke NishihataKeita MasudaTakahiro SuzukiJohan H C ReiberTakayuki OkamuraYoshiharu HiguchiTsunekazu KakutaHiroyasu MisumiKohei AbeNobuyuki KomiyamaKengo TanabeHitoshi MatsuoOn Behalf Of The Decision Qfr InvestigatorsPublished in: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2024)
QFR provided feasible physiological data in Heart Team discussions to determine the optimal revascularisation strategy for MVD. The QFR and FFR approaches agreed substantially in terms of treatment recommendations.
Keyphrases
- study protocol
- clinical trial
- palliative care
- heart failure
- double blind
- open label
- phase iii
- atrial fibrillation
- randomized controlled trial
- phase ii
- quality improvement
- high resolution
- coronary artery bypass grafting
- placebo controlled
- st elevation myocardial infarction
- cross sectional
- st segment elevation myocardial infarction
- clinical practice
- machine learning
- decision making
- mass spectrometry
- acute coronary syndrome
- combination therapy
- replacement therapy
- deep learning
- data analysis